Officials from the Mongolian National Center for Communicable Disease (NCCD) visited SD Biosensor’s factories in Cheongju and Jeungpyeong, North Chungcheong Province, on Nov. 8 to discuss ways to cooperate in the fight against infectious diseases, the Korean company said.
Nine NCCD officials toured SD Biosensor’s total diagnostic platform for liver cancer, cervical cancer, tuberculosis, and respiratory diseases and discussed solutions for early diagnosis of these diseases.
“This visit is a valuable opportunity for us to build a partnership with SD Biosensor and explore cooperation in responding to and combating infectious diseases in Mongolia,” said Dr. Gantungalag Ganbaatar, head of the Tuberculosis Surveillance and Research Department at NCCD.
Lee Min-gyu, head of the International Health Cooperation Division at SD Biosensor, said, “We hope that this visit by the NCCD will strengthen exchanges and cooperation between Korea and Mongolia in responding to and combating infectious diseases. We will continue contributing to international health projects by creating various international cooperation models based on our know-how in responding to infectious diseases and our diagnostic technologies and products.”
Related articles
- Resurgence of Covid-19 raises concerns amidst limited government action
- Korean medical device makers target Middle East market with high potential
- Stock prices of Covid-19 diagnostic kit makers jump as infection resurges
- Major in vitro diagnostics companies suffer sales decline in Q1
- SD Biosensor’s Covid-19 at-home test recalled in US due to contamination
- SD Biosensor, SNUBH to jointly develop next-gen TB diagnostic kits
